U.S. Stimulus Prospects Buoy Strategists Wary of Trump Prognosis
(Bloomberg) -- Markets steadied Monday on easing fears over President Donald Trump's health and increased optimism over fresh U.S. fiscal stimulus, though his prognosis after contracting Covid-19 remains a risk, according to strategists.
Trump's diagnosis boosts the likelihood of Congress and the White House reaching a deal on pandemic relief before the election, they said. Shifting odds on a Democratic victory could impact the dollar, while cyclical stocks would benefit from any stimulus deal, they added.
Doctors on Sunday insisted Trump is doing well and could be discharged as soon as Monday, though contradictory accounts about his illness left lingering confusion about the president's progress.
Here are some strategist views on the current state of play:
Hospital Stay
“Risk sentiment could improve further as Trump's condition appears to be better than originally believed,” said Masakazu Satou, a currency adviser at retail FX brokerage Gaitame Online in Tokyo. “But now we need to see whether Trump will actually be discharged from the hospital later on Monday. If not, that should invite another major bout of volatility to prompt purchases of haven assets.”
Dollar Shorts
Goldman Sachs Group Inc. strategists including Zach Pandl said in a note Sunday that they're unsure how the latest developments will affect polling or the eventual result.
But they added that changes that raise the odds of a Democratic sweep under Joe Biden should accelerate dollar weakness, while events favoring Trump's reelection would bolster the currency. The strategists said they're “holding off on recommending new dollar shorts for now as we await more information on how the president's health situation will affect the race.”
Democratic Sweep
“Lack of a significant safe-haven bid for the dollar so far is telling,” said Win Thin, global head of currency strategy at Brown Brothers Harriman & Co. The recent performance of the U.S. Dollar Index “suggests that the FX market is pricing in greater odds of a Democratic sweep which many (including us) think would be dollar-negative.”
Record Shorts Show New Bets on Steeper Treasury Yield Curve
Asian Equities
Weekend reports suggest “the likelihood of a new stimulus package may be improving as both parties see the urgency” of responding to the impact of Covid-19, JPMorgan Chase & Co. strategists led by Mixo Das wrote in a note Sunday. Overall, the key implication for Asian equities is that “market pricing of election-related risk may be overdone” due to a “very low probability of tail scenarios.”
Value, Cyclicals
“Odds of a roughly $1.7 trillion fiscal package plus a Democratic election sweep have increased and provide support for growth expectations,” said Evercore ISI strategist Dennis DeBusschere in a note Sunday. Such a backdrop would be a “significant” support for value and cyclical stocks short term, he added.
Question of the Day: Can Stocks Advance Without More Stimulus?
Fewer Fears
Monday morning began with a more positive risk tone, said Ray Attrill, head of foreign-exchange strategy at National Australia Bank Ltd. in Sydney, with the possibility of Trump's release from hospital countering fears the U.S. election might not take place on schedule. Increased confidence that U.S. lawmakers may agree on fresh fiscal stimulus is helping the mood, he said.
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.